Gene Query: VNN1

Dataset Description Geneva Score
ARID1A regulates condensin II distribution and chromosomal partition 179.44
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 179.44
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 87.98
Chromatin-informed inference of transcriptional programs in gynecologic cancers 87.98
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 67.28
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 52.96
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 43.93
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 39.24
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 39.24
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 37.23
Transcriptome analysis of virus infected tissues 36.97
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 35.72
RNA seq comparison between scrambled and shGRP78 cells 34.22
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 33.66
Endometrial transcriptome and PGR cistrome in cycling fertile women 33.13
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 33.13
Single-nucleotide-resolution mapping of HBV promoters using CAGE 32.64
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 29.94
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 28.62
HNF1 regulates critical functions of the human epididymis epithelium. 28.37
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 28.37
Transcriptome Profiling of Human Primary Monocytes 25.52
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 24.51
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 23.55
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 22.67
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 22.66
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 21.74
Gene expression patterns define the hepatocyte-like cells derived by different strategies 20.95
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 20.95
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 20.69
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 20.16
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 20.16
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 19.54
Region-specific Innate Antiviral Responses of the Human Epididymis 19.43
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 17.29
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 16.93
RNA Seq of Alagille liver biopsies 15.92
Alagille_Nodder 15.92
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 15.19
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 15.1
The expression profiles of GBC liver metastasis 14.05
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 13.62
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 13.29
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 13.29
Gene expression alterations of pancreatic intraepithlial neoplasia 12.92
Hepatocyte maturation 12.88
Expression by CD133+ cells isolated from the adult human exocrine pancreas 12.17
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 11.88
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 11.53
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 11.53
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 11.45
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 10.9
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 10.84
Transcriptional profile in human S. haematobium infection 10.71
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 10.51
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 9.84
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 9.79
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 9.63
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 8.78
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 8.78
TGF-β regulation of miRNA expression in pancreatic cancer 8.61
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 8.38
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 8.38
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 8.17
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 7.95
Total RNA sequencing of APC mutant and wt colonic organoids 7.94
Gene expression analysis of immortalized human liver progenitor-like cells in culture 7.55
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 7.53
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 7.42
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 7.26
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 7.0
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.99
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 6.92
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 6.9
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 6.82
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 6.79
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 6.69
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 6.62
Changes in human endometrial gland transcriptome over the window of implantation 6.45
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 6.34
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 6.28
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.98
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 5.95
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 5.9
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 5.87
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 5.79
Persistence of stem cell metabolism in cancers as a failure of differentiation 5.75
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 5.64
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 5.62
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 5.62
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 5.59
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 5.39
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 5.39
The gene expression profiles of gallbladder cancer 5.35
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 5.3
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 5.21
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 5.21
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 5.21
Aging-associated patterns in the expression of human endogenous retroviruses 5.16
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 5.09
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 5.0
Efficient derivation of microglia-like cells from human pluripotent stem cells 4.97
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 4.92
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 4.92
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 4.82
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 4.76
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 4.75
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 4.75
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 4.73
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 4.72
NAPRT activation of macrophages 4.66
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  4.65
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 4.64
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 4.64
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.61
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 4.47
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 4.38
JunB control of keratinocyte-mediated inflammation [RNA-seq] 4.37
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 4.37
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.21
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 4.2
Loss of endometrial plasticity in recurrent pregnancy loss 4.2
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 4.14
Molecular analysis of renal cell carcinoma with unclassfied histology 4.11
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 4.11
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.1
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 3.97
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 3.97
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 3.97
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 3.93
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 3.92
RNA sequencing of human pancreatic cancer cell lines 3.77
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 3.65
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 3.64
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 3.61
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 3.59
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 3.53
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 3.52
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.51
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 3.47
Zone dependent distinctive gene expression profile of the normal human liver tissue 3.42
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 3.41
RNA-seq of primary patient AML samples 3.39
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.38
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.37
RNA seq analysis of human Fetal and adult derived Enterospheres 3.35
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.3
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 3.29
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.29
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 3.28
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 3.22
CircRNAome diversity in human mature B-cells, T-cells and monocytes 3.21
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 3.18
Gene profiling of human adult and pediatric liver cancer cells 3.15
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 3.14
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 3.13
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 3.1
Dysregulated immune system networks in war veterans with PTSD 3.01
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 2.97
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.95
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.94
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.92
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 2.91
RNA-seq of stable and unstable section of human atherosclerotic plaques 2.9
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 2.88
Identification of renal resident macrophages across species 2.83
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  2.83
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 2.79
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 2.79
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 2.77
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 2.75
Trascriptome of thyroid cancer-induced macrophages 2.71
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 2.69
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 2.69
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 2.67
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 2.63
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.6
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 2.51
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.45
Hepatic transcriptome of pediatric hepatoblastoma. 2.42
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 2.41
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.41
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 2.37
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 2.36
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 2.32
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 2.32
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 2.3
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 2.26
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 2.25
Transcriptome wide analysis of classically and alternatively activated macrophages 2.22
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.2
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.2
Role of CD133 molecule in WNT response and renal repair 2.18
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.17
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.17
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.17
Non-coding regions are the main source of tumor-specific antigens 2.16
Non-coding regions are the main source of tumor-specific antigens [human] 2.16
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.15
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 2.12
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 2.1
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 2.1
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 2.05
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 2.04
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 2.04
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.03
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 2.01
Transcriptomic analysis of human macrophages in 3D 2.0
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 2.0
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 1.98
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 1.96
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 1.95
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 1.94
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 1.94
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.93
The Human Testis Cell Atlas via Single-cell RNA-seq 1.93
Transcriptome of diurnal human blood neutrophils 1.91
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.9
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 1.9
Gene expression analysis of human hepatocellular cancers 1.9
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.84
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.84
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 1.82
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.79
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 1.78
Finding missing proteins from epigenetically manipulated human cells 1.75
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.74
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.69
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.67
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 1.64
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.63
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 1.62
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.61
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 1.59
Macrophage Ad5f35 M2 Challenge 1.58
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.5
ZIKV infection of monocytes activates inflammasome pathways 1.46
Postnatal lipids drive hepatocyte maturation 1.46
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 1.41
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.41
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.41
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.39
RNAseq of IL-36 stimulated primary human keratinocytes 1.39
RNA-seq of MCF10A cells and CAF 1.38
Gene expression profile difference among renal location in a stone former 1.38
circRNA-sequencing 1.36
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.36
Macrophage Ad5f35 PhenoMap 1.35
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 1.3
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.29
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 1.27
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 1.27
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.26
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.26
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 1.26
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 1.26
Gene expression of collecting duct carcinoma of the kidney 1.25
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 1.22
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 1.22
RNA sequencing of primary human platelets and in vitro cell lines 1.21
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 1.21
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 1.2
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 1.2
Gene expression of thyroid cancer cell lines 1.19
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 1.18
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.18
RNA-sequencing of human liver tissue 1.17
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 1.15
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 1.15
RNA-Seq in neutrophils from Antiphospholipid Syndrome 1.14
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.13
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 1.12
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 1.1
Total RNA sequencing of WT intestinal orgaonids. 1.1
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.09
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 1.08
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 1.08
MCF10A H-Ras RNA-Seq 1.07
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.04
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.03
RNA-Seq and expression data from human adipose tissue 1.03
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.02
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 1.02
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.01
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.0
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 0.99
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 0.98
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.98
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.97
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.96
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.96
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.96
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.96
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.95
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.94
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 0.94
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 0.94
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 0.92
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.92
quanTIseq: quantifying immune contexture of human tumors 0.9
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.89
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 0.89
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.89
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.88
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.88
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.87
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 0.85
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 0.85
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 0.85
Reassessment of Exosome Composition 0.85
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.85
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.82
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 0.8
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 0.8
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 0.8
Role of cervicovaginal microbiota in genital inflammation 0.78
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.78
Reprogrammed myeloid cell transcriptomes in NSCLC 0.77
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.76
RNA-seq in HepG2 and IMR90 cells 0.76
Evolution of a transcriptional regulator from a transmembrane nucleoporin 0.76
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 0.75
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 0.74
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  0.74
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 0.74
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.74
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 0.73
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 0.73
Electronic cigarettes 0.73
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.72
Effects of rFVIIIFc on human macrophages 0.71
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.71
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.7
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.68
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 0.68
Intron retention induced by microsatellite expansions as a disease biomarker. 0.68
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.67
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.67
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.67
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 0.67
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.67
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.66
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 0.63
Transcriptome of EBV-infected gastric cancer cell lines 0.63
Common inflammatory pathways between NEC and Crohn's disease 0.62
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.61
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.61
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 0.61
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.61
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.61
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 0.61
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.6
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 0.59
A map of gene expression in neutrophil-like cell lines 0.59
RNA Sequencing of three pairs of gastric cancer 0.59
Gene expression analysis of human liver progenitor-like cells in culture 0.58
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 0.56
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 0.56
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 0.56
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 0.54
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 0.54
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.53
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.53
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 0.52
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.52
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 0.52
Human neutrophil genome during PMA- and E. coli encounter-induced activation 0.52
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 0.51
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 0.51
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.51
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.51
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 0.5
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 0.5
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 0.49
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.49
Identification of expressed and conserved human non-coding RNAs 0.49
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.49
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.48
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.48
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.48
Nonpregnant and term pregnant human myometrial tissues 0.46
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 0.46
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.46
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.46
Evaluating pre-clinical models for studying NASH driven HCC. 0.45
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.45
Anti-inflammatory effect of indoleacrylic acid (IA) 0.45
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 0.44
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.44
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 0.44
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.44
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.42
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.42
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.42
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 0.41
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.41
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 0.41
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.41
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.41
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.4
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.4
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.39
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 0.39
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.39
Transcriptomes of human monocytes after ex vivo exposure to uric acid 0.38
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.38
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.37
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.37
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 0.35
Discovering human diabetes-risk gene function with genetics and physiological assays 0.35
Repurposing of promoters and enhancers during mammalian evolution 0.32
Tpl-2 small molecule project 0.32
Tpl-2 and MEK small molecule inhibitors 0.32
Clinker: visualizing fusion genes detected in RNA-seq data 0.31
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.3
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.3
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.3
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.29
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 0.29
Human islets of varying quality: the good, the (not so) bad and the ugly 0.29
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.29
LncRNA expression profiling of ischemic stroke patients 0.28
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.27
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.25
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.24
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.24
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.23
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 0.22
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.22
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.21
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.21
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.21
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 0.21
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.2
RNAseq analysis of ruxolitinib treated breast cancers 0.2
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.2
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.2
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.19
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.19
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.19
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.19
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.17
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 0.17
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 0.17
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 0.16
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.16
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.16
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.15
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.15
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.14
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.14
ML29755 RNA-seq data 0.13
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.13
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 0.13
RNA-seq of CD33 KO and control HSPCs 0.13
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.12
Expression analysis of the TAF1 syndrome 0.11
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.11
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.11
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.11
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.11
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.11
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.1
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.1
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.1
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 0.1
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.09
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.09
Measure transcript integrity using RNA-seq data 0.08
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.08
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.08
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.07
Transcriptome analysis of CNS leukemia 0.07
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.07
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.07
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.06
STX4 Over-Expression in Human islets 0.06
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.05
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.05
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 0.05
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 0.05
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.05
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.05
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.05
Defective structural RNA processing in relapsing-remitting multiple sclerosis 0.04
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.04
Downregulation of LATS kinases alters p53 to promote cell migration 0.04
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 0.04
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.03
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.03
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.03
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.03
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 0.03
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.02
Specific molecular signatures underlie response to decitabine in CMML 0.02
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.02
The transcriptome of Kawasaki Disease arteritis 0.01
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.01
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.01
Transcriptome analysis of peripheral blood monocytes 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation